Global (United States, European Union and China) Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Research Report 2019-2025

Published Date : 2019-08-12

Published By : Qy Research

Category : Pharma & Healthcare

No. of Pages : 116

DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contrast to whole-cell, inactivated DTP (aka DTwP). The acellular vaccine uses selected antigens of the pertussis pathogen to induce immunity. Because it uses fewer antigens than the whole cell vaccines, it is considered safer, but it is also more expensive. Recent research suggests that the DTP vaccine is more effective than DTaP in conferring immunity; this is because DTaP's narrower antigen base is less effective against current pathogen strains.
In 2019, the market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine.

This report studies the global market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc

Market Segment by Product Type
Immune DTaP Vaccine
Therapy DTaP Vaccine

Market Segment by Application
Adult
Pediatric

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by Type (2019-2025)
1.3.2 Immune DTaP Vaccine
1.3.3 Therapy DTaP Vaccine
1.4 Market Segment by Application
1.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application (2019-2025)
1.4.2 Adult
1.4.3 Pediatric
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size
2.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue 2014-2025
2.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales 2014-2025
2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Growth Rate by Regions
2.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Regions 2014-2019
2.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers
3.1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers 2014-2019
3.1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Manufacturers
3.4 Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market
3.6 Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Immune DTaP Vaccine Sales and Revenue (2014-2019)
4.1.2 Therapy DTaP Vaccine Sales and Revenue (2014-2019)
4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
4.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Type
4.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application

6 United States
6.1 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Company
6.2 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Type
6.3 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Application

7 European Union
7.1 European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Company
7.2 European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Type
7.3 European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Application

8 China
8.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Company
8.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Type
8.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Application

9 Rest of World
9.1 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Company
9.2 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Type
9.3 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Application
9.4 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Countries
9.4.1 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries
9.4.2 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.1.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.1.5 Sanofi Pasteur Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.2.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.2.5 GlaxoSmithKline Recent Development
10.3 Protein Sciences Corporation
10.3.1 Protein Sciences Corporation Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.3.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.3.5 Protein Sciences Corporation Recent Development
10.4 Novartis AG
10.4.1 Novartis AG Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.4.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.4.5 Novartis AG Recent Development
10.5 Seqirus
10.5.1 Seqirus Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.5.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.5.5 Seqirus Recent Development
10.6 Merck Sharp & Dohme Corp
10.6.1 Merck Sharp & Dohme Corp Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.6.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.6.5 Merck Sharp & Dohme Corp Recent Development
10.7 Astellas Pharma US, Inc
10.7.1 Astellas Pharma US, Inc Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.7.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.7.5 Astellas Pharma US, Inc Recent Development
10.8 Pfizer Inc
10.8.1 Pfizer Inc Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.8.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.8.5 Pfizer Inc Recent Development
10.9 Johnson & Johnson
10.9.1 Johnson & Johnson Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.9.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.9.5 Johnson & Johnson Recent Development
10.10 Lanzhou Institute of Biological Products Co., Ltd
10.10.1 Lanzhou Institute of Biological Products Co., Ltd Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.10.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Development
10.11 AstraZeneca
10.12 Emergent BioSolutions Inc

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Channels
11.2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors
11.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers

12 Market Forecast
12.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue Forecast 2019-2025
12.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Type
12.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Application
12.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast by Regions
12.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Regions 2019-2025
12.4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer


List of Tables and Figures

Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Picture
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Key Market Segments
Table Major Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Covered in This Report
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by Type 2019-2025 (K Doses) & (Million US$)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Shar by Type 2014-2025
Figure Immune DTaP Vaccine Figures
Table Major Manufacturers of Immune DTaP Vaccine
Figure Therapy DTaP Vaccine Figures
Table Major Manufacturers of Therapy DTaP Vaccine
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application 2019-2025 (K Doses)
Figure Adult Use Case
Figure Pediatric Use Case
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Report Years Considered
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size 2014-2025 (Million US$)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales 2014-2019 (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Regions 2014-2019 (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Regions 2014-2019
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Regions 2014-2019
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Regions in 2019
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers (2014-2019) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Manufacturers in 2019
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Value Share by Manufacturers in 2019
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (2014-2019) (USD/Dose)
Table Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Plants/Factories Distribution
Table Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Area Served
Table Date of Key Manufacturers Enter into Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market
Table Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Immune DTaP Vaccine Sales and Revenue (2014-2019) (K Doses) & (Million US$)
Table Global Therapy DTaP Vaccine Sales and Revenue (2014-2019) (K Doses) & (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2014-2019) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Type (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type in 2018
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Type (2014-2019) (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Type (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Type (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Type in 2018
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Type 2014-2019 (USD/Dose)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2014-2019) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Application (2014-2019)
Figure Global Sales Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application (2014-2019)
Figure Global Sales Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application (2014-2019)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2014-2019) (K Doses)
Table United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company (2014-2019)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company in 2019
Table United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2014-2019) (K Doses)
Table United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2014-2019)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Type in 2019
Table United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2014-2019) (K Doses)
Table United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2014-2019)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application in 2019
Figure European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2014-2019) (K Doses)
Table European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company (2014-2019)
Figure European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company in 2019
Table European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2014-2019) (K Doses)
Table European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2014-2019)
Figure 2018 European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Type
Table European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2014-2019) (K Doses)
Table European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2014-2019)
Figure 2018 European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2014-2019) (K Doses)
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company (2014-2019)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company in 2019
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2014-2019) (K Doses)
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2014-2019)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Type in 2019
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2014-2019) (K Doses)
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2014-2019)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application in 2019
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2014-2019) (K Doses)
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company (2014-2019)
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company in 2019
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2014-2019) (K Doses)
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2014-2019)
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Type in 2019
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2014-2019) (K Doses)
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2014-2019)
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application in 2019
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries (2014-2019) (K Doses)
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries (2014-2019)
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries in 2019
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries (2014-2019)
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries in 2019
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Description and Business Overview
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Sanofi Pasteur Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Protein Sciences Corporation Company Details
Table Protein Sciences Corporation Description and Business Overview
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Protein Sciences Corporation Recent Development
Table Novartis AG Company Details
Table Novartis AG Description and Business Overview
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Novartis AG Recent Development
Table Seqirus Company Details
Table Seqirus Description and Business Overview
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Seqirus Recent Development
Table Merck Sharp & Dohme Corp Company Details
Table Merck Sharp & Dohme Corp Description and Business Overview
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Merck Sharp & Dohme Corp Recent Development
Table Astellas Pharma US, Inc Company Details
Table Astellas Pharma US, Inc Description and Business Overview
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Astellas Pharma US, Inc Recent Development
Table Pfizer Inc Company Details
Table Pfizer Inc Description and Business Overview
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Pfizer Inc Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Johnson & Johnson Recent Development
Table Lanzhou Institute of Biological Products Co., Ltd Company Details
Table Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Lanzhou Institute of Biological Products Co., Ltd Recent Development
Table AstraZeneca Company Details
Table Emergent BioSolutions Inc Company Details
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Value Chain
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors List
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers List
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses) & (Million US$)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Type 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Type 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share Forecast by Type 2019-2025
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Application 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Application 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share Forecast by Application 2019-2025
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Regions 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Regions 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share Forecast by Regions 2019-2025
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-213-4282

sales@researchreportcenter.com